Diclofenac sodium injection (Dyloject®): In postoperative pain

Drugs

Volumn 68, Issue 1, 2008, Pages 123-130

  McCormack, Paul L ^a,b   Scott, Lesley J ^a,b  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

^b WOLTERS KLUWER HEALTH   (United States)

Author keywords

Adis Drug Profiles; Diclofenac, general; Postoperative pain

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BENZYL ALCOHOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; DYLOJECT; KETOROLAC; PLACEBO; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANALGESIA; AREA UNDER THE CURVE; BLEEDING; BOLUS INJECTION; CONTINUOUS INFUSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG TOLERABILITY; FATIGUE; HUMAN; INCIDENCE; INJECTION SITE BURNING; INJECTION SITE REACTION; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NONHUMAN; POSTOPERATIVE PAIN; RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; THROMBOPHLEBITIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 37249089884     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200868010-00008     Document Type: Review

References (18)

1. White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg 2002; 94: 577-85
2. Filos KS, Lehmann KA. Current concepts and practice in post-operative pain management: need for a change? Eur Surg Res 1999; 31 (2): 97-107
3. Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002 Jun; 3 (3): 159-80
4. National Pharmaceutical Council. Pain: current understanding of assessment, management, and treatments [online]. Available from URL: http://www.npcnow.org/resources/PDFs/painmonograph.pdf [Accessed 2007 Jun 5]
5. Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988 Mar; 35 (3): 244-85
6. Barden J, Edwards J, Moore RA, et al. Single dose oral diclofenac for postoperative pain. Cochrane Database Syst Rev 2004; (2): CD004768
7. Leeson RM, Harrison S, Ernst CC, et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Reg Anesth Pain Med 2007 Jul-Aug; 32 (4): 303-10
8. Brogden RN, Heel RC, Pakes GE, et al. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 1980 Jul; 20 (1): 24-48
9. Maier R, Menasse R, Riesterer L, et al. The pharmacology of diclofenac sodium (Voltarol). Rheumatol Rehabil 1979; Suppl. 2: 11-21
10. Chandrasekharan NV, Dai H, Roos KLT, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002 Oct 15; 99 (21): 13926-31
11. Javelin Pharmaceuticals Inc. A phase 1, randomized, analytically blind, fasted, single-dose, four-way crossover study of the bioavailability of one dose level of parenteral DIC075V (diclofenac sodium 75 mg/2 ml), administered intramuscularly and intravenously, vs. parenteral Voltarol® (diclofenac sodium 75 mg/3 ml) administered intramuscularly and intravenously in healthy adult volunteers. New York: Javelin Pharmaceuticals Inc., 2004. (Data on file)
12. Christensen K, Daniels S, Bandy D, et al. Dyloject™, a novel injectable diclofenac: efficacy of unexpectedly low doses and faster onset than ketorolac [abstract no. 643]. Eur J Pain 2006; 10 Suppl. S1: S168
13. Javelin Pharmaceuticals Inc. A randomized, double-blind, placebo- and comparator-controlled, single-dose, parallel-group comparison of the analgesic efficacy and safety of intravenous DIC075V (diclofenac sodium injection), ketorolac tromethamine and placebo following surgery. New York: Javelin Pharmaceuticals Inc., 2006. (Data on file)
14. Data on file, Javelin Pharmaceuticals Inc., 2007
15. Wallerstein K. A cost minimization analysis of IV bolus versus IV infusion diclofenac in post-operative pain [abstract and poster]. 10th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research; 2007 Oct 20-23; Dublin
16. Catalano MA. Worldwide safety experience with diclofenac. Am J Med 1986 Apr 28; 80 (4B): 81-7
17. Novartis Pharmaceuticals UK Ltd. Voltarol ampoules: summary of product characteristics [online]. Available from URL: http://emc.medicines.org.uk [Accessed 2007 May 30]
18. Javelin Pharmaceuticals Inc. Javelin Pharmaceuticals receives marketing authorization approval for Dyloject® in the United Kingdom [media release]. 2007 Oct 31